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Positive result 362 (16.4) 616 (26.7)
Co‐detection 5 (0.23) 47 (2)
C. diff test repeated < 3 days? 23 (1) 30 (1.3)
Redundant testing ‐‐ 55 (2.4)
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• There were fewer stool tests processed during the intervention period 
than prior to the introduction of the comprehensive stool PCR test 
(3878 vs. 3317, Table 1, Figure 1). This may be secondary to the 
comprehensive stool PCR test’s ability to look for multiple pathogens, 
resulting in a decreased need for other routine stool studies. 
• There was a decrease in the use of conventional C. difficile tests 
during the intervention period than prior to the implementation of the 
stool PCR test (54% vs. 64%, Figure 1). This may be secondary to a 
lack of understanding about when it is appropriate to use the 
comprehensive stool PCR versus C. difficile testing.  
• There was an increase in the percentage of patients receiving repeat 
testing within 30 days of their initial stool test (15% vs. 18.9%, Table 1). 
This is likely secondary to confusion regarding the new comprehensive 
stool PCR test and lack of knowledge regarding when repeat testing is 
appropriate.
• Redundant stool testing occurred in 2015 which is likely secondary to 
lack of understanding and proper protocol for stool test ordering.  
• More patients were identified with C. difficile infection in 2015 versus 
2014 (440 vs. 325, Table 2).  This may be related to inappropriate 
ordering of the comprehensive stool PCR which could have identified 
patients colonized with C. difficile.
• More pathogens were identified following the implementation of the 
comprehensive stool PCR test than prior to its institution (616 vs. 362, 
Table 1; Table 2). Again, this is likely attributable to the ability of the 
stool PCR test to detect multiple pathogens.
• More co-detections were identified in 2015 (47 (2%) vs. 5 (0.23%), 
Table 1). This is attributable to the introduction of the comprehensive 
stool PCR test and consistent with nationwide trends with the use of 
this test.
• A total of 4,505 patients from Lehigh Valley Cedar Crest (CC) 
and Muhlenberg (MHC) campuses underwent stool sampling 
and met the predefined study inclusion criteria. 
– 2,202 patients from January 1st 2014 to December 31st 2014, prior to 
the institution of the comprehensive stool PCR test. 
– 2,303 patients from January 5th 2015 to December 31st 2015, during 
the institution of the stool PCR test. 
• Patients were identified from stool culture results provided by the 
microbiology laboratory and compiled into a spreadsheet.  
• Patients were ordered numerically by medical record number 
and culture results were organized according to the dates they 
were reported and analyzed for quantity, positive and negative 
cultures, identification of pathogens, repeat and redundant 
testing, and co-detection. 
• All variables were compared and analyzed using basic statistical 
tests. 
• The comprehensive stool PCR test is currently being used by Lehigh 
Valley Cedar Crest and Muhlenberg campuses in an ongoing effort to 
improve patient care and reduce cost. 
– This study warrants a new protocol in order to improve the usage of the comprehensive 
stool PCR
– In particular, appropriate ordering needs to be addressed to help providers:
• Choose C. difficile testing in patients hospitalized > 3 days
• Avoid redundant testing
• Understand when repeat stool testing is appropriate  









The diagnosis and management of inpatients with diarrhea 
can be complex.  Multiple tests are necessary to make a 
diagnosis and often tests are ordered sequentially and may 
be performed in different laboratories.  Molecular 
polymerase chain reaction (PCR) stool testing is a new 
method of pathogen identification that has an improved 
detection rate over conventional testing with a faster turn-
around time. Health Network Laboratories implemented the 
FilmArray molecular stool PCR test for inpatients 
hospitalized at Lehigh Valley Health Network’s Cedar Crest 
and Muhlenberg campuses on January 5th, 2015, while 
concurrently discontinuing other routine stool tests. 
OBJECTIVES
The purpose of the study is to see if the implementation of a new 
comprehensive stool PCR test has changed inpatient stool testing 
orders at LVHN Cedar Crest campus by evaluating:
1. If there is a difference in the total number of stool tests 
performed in the pre-intervention versus the intervention 
period
2. If there is a difference in the number of stool testing 
performed per patient in the pre-intervention versus the 
intervention period, such as duplicates or repeat testing; 
3. If is a difference in the number of C. difficile PCR testing 
performed in the pre-intervention versus the intervention 
period; 
4. If there is a difference in gastrointestinal pathogens 
identified in the pre-intervention versus the intervention 
period, and are any co-detections identified.







Campylobacter jejuni 22 (1) 21 (0.91)









Giardia lamblia 2 (0.09) 1 (0.04)
Ascaris lumbricoides 0 1 (0.04)
EAEC 0 20 (0.87)
EPEC 0 19 (0.83)
STEC 1 (0.05) 7 (0.30)
ETEC 0 4 (0.17)
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